drugset / Trial / NCT02084511
Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the effectiveness of BI 1026706 powder for reconstitution of an oral solution compared to placebo and the relative effectiveness compared to Celecoxib.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-10
- Completion
- 2014-10
Outcome
Missed primary endpoint
registry analysis (superiority or other test); BI 50 mg PfOS vs Placebo; Mean Difference (Final Values) 27.39 (95% CI -76.3 to 131.1) NCT02084511 ↗
registry analysis (superiority or other test); BI 200 mg PfOS vs Placebo; Mean Difference (Final Values) 53.48 (95% CI -50.2 to 157.1) NCT02084511 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1026706 | Unknown | — | Oral |
| Subject | Celecoxib | Other / unclassified | — | — |
Indications
No indication recorded.